搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
证券之星
57 分钟
港股异动 | 宜明昂科-B(01541)午后涨近4% 公司发布新药产品研发策略 ...
值得注意的是,宜明昂科近日公告称,根据与Instil Bio的全资附属SYNBIOTX有关IMM2510及IMM27M的授权及合作协议,公司已自SynBioTx收取500万美元的近期付款,并已收取付款合共1500万美元。公司预计未来将收取不超过3500万美元余下潜在付款。据悉,宜明昂科是为数不多的同时拥有PD- (L)1, VEGF和CTLA-4三个靶点管线的创新药企。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Alabama mass shooting
Daylight saving time
Ga. suspect's mom indicted
San Francisco homelessness
Released after guilty plea
Biden hosts 'Quad' summit
Suns broadcaster dies
Pandas leaving for China
CA firefighter held for arson
Drug price challenge revived
J&J unit files for bankruptcy
Donlon's homes searched
Former WA governor dies
TN abortion law blocked
CA bill to protect kids online
ISR raids Al Jazeera office
No. 1 at box office again
Boeing defense chief exits
SC 1st execution in 13 years
Robinson loses key staff
California plastic bag ban
Iran coal mine blast
Sesame Place suit verdict
Hezbollah rockets hit Israel
Free COVID-19 tests
PM Modi visits US
Dolphins legend Morris dies
Economic speech this week
No govt. shutdown for now
Trump to campaign in MI
反馈